✦ LIBER ✦

P.1.c.023 Neuroendocrine effects and safety of intravenously administered desmopressin in healthy volunteers

✍ Scribed by G. Jacobs; E.G.J. Hulskotte; H.H. Zuurman; J. Burggraaf; J. Elassais-Schaap; P.A.M. Peeters; J.M.A. van Gerven; G. Ruigt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacodynamic and pharmacokinetic effe

✍ Zuurman, L; Passier, P.; de Kam, M.; Kleijn, H.; Cohen, A.; van Gerven, J. 📂 Article 📅 2008 🏛 SAGE Publications 🌐 English ⚖ 373 KB

P.1.c.034 Pharmacokinetics of licarbazep

✍ C. Souppart; A. Gardin; G. Greig; S. Balez; Y. Batard; A. Krebs-Brown; S. Appel- 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Sa1222 Results of a Safety and Tolerabil

✍ Olson, Allan; Timony, Gregg; Hartung, Jeffrey P.; Smith, Heather; Peach, Robert 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 210 KB

P.1.c.001 Acute psychomotor, memory and

✍ G. Dumont; J. van Hasselt; M. de Kam; J. van Gerven; D. Touw; J. Buitelaar; R. V 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

P.1.c.029 A comparative pharmacokinetic

✍ A.H. Andreasen; K. Brøsen; P. Damkier 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Phase I clinical trial safety of DNA- an

✍ Inese Cebere; Lucy Dorrell; Helen McShane; Alison Simmons; Sheena McCormack; Cla 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 289 KB